RSV F evolution escapes some monoclonal antibodies but does not strongly erode neutralization by human polyclonal sera.

ABSTRACT: Vaccines and monoclonal antibodies targeting the respiratory syncytial virus (RSV) fusion protein (F) have recently begun to be widely used to protect infants and high-risk adults. Some other viral proteins evolve to erode polyclonal antibody neutralization and escape individual monoclonal antibodies. However, the impact of RSV F evolution on antibody neutralization is not yet thoroughly understood. Here, we develop an experimental system for measuring neutralization titers against RSV F using pseudotyped lentiviral particles. This system is easily adaptable to evaluate neutralization of relevant clinical strains. We apply this system to demonstrate that the natural evolution of RSV F leads to escape from some monoclonal antibodies, but at most modestly affects neutralization by polyclonal

SUBMITTER: Simonich CAL 

PROVIDER: S-EPMC12282093 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature